Halozyme Therapeutics
HALO
#2209
Rank
$6.56 B
Marketcap
$51.55
Share price
1.36%
Change (1 day)
42.72%
Change (1 year)

Halozyme Therapeutics (HALO) - Total debt

Total debt on the balance sheet as of March 2024 : $1.50 B

According to Halozyme Therapeutics's latest financial reports the company's total debt is $1.50 B. A companyโ€™s total debt is the sum of all current and non-current debts.

Halozyme Therapeutics - Total debt on balance sheet (from 2011 to 2024)

Total debt by year

Year Total debt Change
2023-12-31$1.49 B-0.45%
2022-12-31$1.50 B71.8%
2021-12-31$0.87 B120.7%
2020-12-31$0.39 B-1.33%
2019-12-31$0.40 B218.55%
2018-12-31$0.12 B-37.54%
2017-12-31$0.20 B-6.59%
2016-12-31$0.21 B334.69%
2015-12-31$49.83 M-0.05%
2014-12-31$49.86 M0.18%
2013-12-31$49.77 M59.98%
2012-12-31$31.11 M
2011-12-31$N/A

Total debt for similar companies or competitors

Company Total debt differencediff. Country
$33.63 B 2,140.82%๐Ÿ‡บ๐Ÿ‡ธ USA
$68.70 B 4,477.85%๐Ÿ‡บ๐Ÿ‡ธ USA
$26.21 B 1,646.40%๐Ÿ‡บ๐Ÿ‡ธ USA
$20.36 B 1,257.01%๐Ÿ‡ซ๐Ÿ‡ท France
$14.17 B 844.11%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.26 B-82.16%๐Ÿ‡บ๐Ÿ‡ธ USA